Y-mAbs Therapeutics, Inc. (YMAB)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 14.84 |
| Open | 14.92 |
| Bid | 14.67 x 400 |
| Ask | 14.76 x 400 |
| Day's range | 14.35 - 15.13 |
| 52-week range | 4.60 - 20.90 |
| Volume | |
| Avg. volume | 391,465 |
| Market cap | 643.961M |
| Beta (5Y monthly) | 0.76 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Y-mAbs Therapeutics (NASDAQ:YMAB) rises 9.6% this week, taking one-year gains to 161%
Unfortunately, investing is risky - companies can and do go bankrupt. But when you pick a company that is really...
- Zacks
Wall Street Analysts Think YmAbs Therapeutics (YMAB) Could Surge 31.33%: Read This Before Placing a Bet
The average of price targets set by Wall Street analysts indicates a potential upside of 31.3% in YmAbs Therapeutics (YMAB). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
- Zacks
YmAbs Therapeutics (YMAB) Surges 8.2%: Is This an Indication of Further Gains?
YmAbs Therapeutics (YMAB) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
© 2024 Yahoo. All rights reserved.